CLC 2024
Canadian Leadership Council on Drug Plan Partnerships

May 7, 2024  | Vantage Venues, Toronto

May 7, 2024

8:00 – 9:00 AM:

Breakfast (St. Andrew’s Lounge)

9:00 – 9:05 AM:

Introduction (St. Andrew’s Hall)

Facilitators:

Francesca Allman, director of sales, Benefits Canada

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

9:05 – 9:20 AM:

The value of medications and the private payer market

Speaker:

Ugur Gunaydin, vice-president and general manager, Amgen Canada Inc.

9:20 – 9:40 AM:

Private drug claims: Trends and cost drivers

Speaker:

Joe Farago, executive director, private payers and investment, Innovative Medicines Canada

9:40 – 10:10 AM:

Moderated discussion

Facilitator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

10:10 – 10:45 AM:

Networking break (St. Andrew’s Lounge)

10:45 – 11:10 AM:

Managing risk

Speaker:

Paul Henricks, associate director, data innovation and insights, PDCI Market Access

11:10 – 11:40 AM:

Moderated discussion

Facilitator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

11:40 AM – 12:20 PM:

Lunch (St. Andrew’s Lounge)

12:20 – 12:50 PM:

The role of private payers in chronic disease management

Speakers:

Amine Bouchaib, director, patient access, obesity and rare disease, Novo Nordisk Canada

Martine Carbonneau, director, field patient access, Novo Nordisk Canada 

12:50 – 1:20 PM:

Moderated discussion

Facilitator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

1:20 – 2:05 PM:

Panel: Best practices for drug plan management

This panel discussion will include highlights from Benefits Canada’s Plan Sponsor’s Guide to Drug Formularies and Prior Authorization.

Panellists:

Denise Balch, project manager, Simplify Prior Authorization Initiative; principal consultant, Crosslinks; and president, Connex Health

Philippe Lagacé, principal, health and benefits, Mercer Marsh Benefits

Nina Lathia, health economics consultant and founder and chief executive officer, Healthcare Decision Making

Kim Steele, director, government and community relations, Cystic Fibrosis Canada

Moderator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

2:05 – 2:35 PM:

Moderated discussion

Facilitator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

2:35 – 3:35 PM:

Discussion: Recommendations from council members

Facilitator:

Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.

3:35 – 3:45 PM:

Closing remarks

Facilitator:

Francesca Allman, director of sales, Benefits Canada

SPONSORS
SUPPORTING SPONSORS